Research programme: astaxanthin derivatives - Albany Molecular Research/Mera

Drug Profile

Research programme: astaxanthin derivatives - Albany Molecular Research/Mera

Alternative Names: Astaxanthin derivatives research programme - Albany Molecular Research/Mera

Latest Information Update: 09 Oct 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mera Pharmaceuticals; University of Hawaii
  • Developer Albany Molecular Research Inc; Mera Pharmaceuticals; National Cancer Institute (USA)
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 09 Oct 2002 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 20 Sep 2002 Aquasearch is now called Mera Pharmaceuticals
  • 15 Jan 2001 Drug discovery agreement between Aquasearch and the University of Hawaii
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top